Lv7
5008 积分 2021-08-24 加入
Unresectable stage III non-small-cell lung cancer: state of the art and challenges
1个月前
已完结
Atezolizumab Before and After Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer: A Phase II Nonrandomized Controlled Trial
1个月前
已完结
Tislelizumab plus sitravatinib or anlotinib as maintenance therapy in extensive-stage small-cell lung cancer: Results of two prospective phase II studies
1个月前
已完结
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial
1个月前
已完结
A prospective phase Il trial of hypofractionated stereotactic radiotherapy (FSRT) for patients with 1-lo brain metastases from breast cancer
1个月前
已关闭
First-in-human phase 1 study of an orally bioavailable vascular-disrupting agent DX1002 in patients with advanced solid tumors
2个月前
已关闭
Perioperative Nivolumab and Chemotherapy in Stage III Non-Small-Cell Lung Cancer
2个月前
已完结
Surgeon preferences for self-treatment in locally advanced non-small cell lung cancer: Would we practice what we preach?
3个月前
已完结
Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE)
3个月前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
4个月前
已完结
皖公网安备34019202002308
